Published in Drugs Exp Clin Res on January 01, 1987
Sucralfate reduces the gastrointestinal absorption of norfloxacin. Antimicrob Agents Chemother (1989) 1.74
Inhibition of norfloxacin absorption by antacids. Antimicrob Agents Chemother (1990) 1.38
Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers. Antimicrob Agents Chemother (1998) 0.93
Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Ascanius Project Collaborative Group. Pediatr Infect Dis J (1999) 2.52
In vitro activity of teichomycin and vancomycin alone and in combination with rifampin. Antimicrob Agents Chemother (1983) 2.51
Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol (2000) 1.98
Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca. Antimicrob Agents Chemother (1998) 1.85
Susceptibility of Streptococcus pneumoniae strains isolated in Italy to penicillin and ten other antibiotics. J Antimicrob Chemother (1995) 1.84
European multicentre evaluation of a commercial system for identification of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1996) 1.79
Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. J Antimicrob Chemother (1993) 1.54
Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group. Clin Infect Dis (1999) 1.54
Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey. J Antimicrob Chemother (1998) 1.51
Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines. J Chemother (2005) 1.45
In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors. Antimicrob Agents Chemother (2000) 1.43
Teicoplanin Chemistry and Microbiology. J Chemother (2000) 1.40
Evaluation of spontaneous contamination of ocular medications. Chemotherapy (2001) 1.39
Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolates recovered in Italy from 1993 to 1996. J Clin Microbiol (1998) 1.38
In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin. Antimicrob Agents Chemother (1986) 1.35
Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy. J Antimicrob Chemother (1999) 1.35
In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteria. Antimicrob Agents Chemother (1988) 1.33
Glutathione in gingival crevicular fluid and its relation to local antioxidant capacity in periodontal health and disease. Mol Pathol (2002) 1.28
Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. J Antimicrob Chemother (2002) 1.25
Biophysical properties of N4 coliphage. Biochim Biophys Acta (1966) 1.19
The physical properties of the deoxyribonucleic acid from N4 coliphage. Biochim Biophys Acta (1966) 1.18
Rifampicin-resistant RNA polymerase and NAD transferase activities in coliphage N4 virions. Nature (1976) 1.12
Novel transcribing activities in N4-infected Escherichia coli. Virology (1974) 1.12
Short-chain fatty acids produced by anaerobic bacteria alter the physiological responses of human neutrophils to chemotactic peptide. J Infect (1987) 1.11
Detection of SHV-5 extended-spectrum beta-lactamase in Klebsiella pneumoniae strains isolated in Italy. Eur J Clin Microbiol Infect Dis (1996) 1.01
Monuril and modification of pathogenicity traits in resistant microorganisms. Eur Urol (1987) 1.01
Resistance patterns of lower respiratory tract pathogens in Europe. Int J Antimicrob Agents (2000) 1.00
A rapid procedure for the purification of bacterial viruses. Virology (1966) 0.99
Antibiotic resistance of clinical isolates of Enterococcus in Italy. Clin Infect Dis (1992) 0.99
Inhibition of motility of Pseudomonas aeruginosa and Proteus mirabilis by subinhibitory concentrations of azithromycin. Eur J Clin Microbiol Infect Dis (1992) 0.98
Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. Int J Antimicrob Agents (2008) 0.97
Dvelopment of coliphage N4: ultrastructural studies. J Virol (1974) 0.95
Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J Chemother (2009) 0.94
Estimation of serum antibody to subgingival species using checkerboard immunoblotting. Oral Microbiol Immunol (1997) 0.94
Rapid disappearance from the intestinal tract of bacteria resistant to rifaximin. Drugs Exp Clin Res (1986) 0.93
Mannose-inhibitable adhesins and T3-T7 receptors of Klebsiella pneumoniae inhibit phagocytosis and intracellular killing by human polymorphonuclear leukocytes. Infect Immun (1982) 0.92
Evolution of antibiotic resistance in gram-positive pathogens. J Chemother (2000) 0.92
Preparation and antimicrobial activity of 1-arylazo-3,4,6,7,8,9-hexahydroquinolizines. Farmaco (1990) 0.92
Seasonal variations in nasopharyngeal carriage of respiratory pathogens in healthy Italian children attending day-care centres or schools. J Med Microbiol (2001) 0.91
Prevalence of nosocomial infections in 15 Italian hospitals: first point prevalance study for the INF-NOS project. Infection (2003) 0.91
Intracellular pH regulates the production of different oxygen metabolites in neutrophils: effects of organic acids produced by anaerobic bacteria. J Leukoc Biol (1991) 0.91
Synthesis and antimicrobial activity of arylazoenamines. Farmaco (1993) 0.91
Epidemiology of major respiratory pathogens. J Chemother (2001) 0.90
Emergence of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains and spread of an isolate of sequence type 258 in the neuro-rehabilitation unit of an Italian hospital. J Chemother (2010) 0.90
Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). Int J Antimicrob Agents (2005) 0.90
Ideal microbiological and pharmacological characteristics of a quality antimicrobial agent: comparing original and generic molecules. J Chemother (2007) 0.88
Microbial epidemiology patterns of surgical infection pathogens. J Chemother (2001) 0.88
In vitro activities of rifapentine and rifampin, alone and in combination with six other antibiotics, against methicillin-susceptible and methicillin-resistant staphylococci of different species. Antimicrob Agents Chemother (1985) 0.88
Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. Int J Antimicrob Agents (2007) 0.87
A non-absorbable rifamycin for treatment of hepatic encephalopathy. Drugs Exp Clin Res (1985) 0.87
Antibiotic susceptibility patterns and serotypes of antibiotic resistant and/or invasive Streptococcus pneumoniae strains circulating in Italy. Microb Drug Resist (2000) 0.87
Lysogenic conversion in Klebsiella pneumoniae: system which requires active immunity regulation for expression of the conversion phenomenon. J Virol (1978) 0.87
Antibacterial resistance in Streptococcus pneumoniae and Haemophilus influenzae from Italy and Spain: data from the PROTEKT surveillance study, 1999-2000. J Chemother (2003) 0.87
Serum IgG2 level, Gm(23) allotype and FcgammaRIIa and FcgammaRIIIb receptors in refractory periodontal disease. J Clin Periodontol (1998) 0.87
Susceptibility in vitro of gram-positive aerobe and anaerobe bacteria to ofloxacin. Drugs Exp Clin Res (1987) 0.86
N-acetylcysteine enhances in vitro the intracellular killing of Staphylococcus aureus by human alveolar macrophages and blood polymorphonuclear leukocytes and partially protects phagocytes from self-killing. J Lab Clin Med (1994) 0.86
Antimycobacterial chemotherapy in two cases of inflammatory bowel disease. Lancet (1988) 0.86
Evaluation of a computer-assisted method of analysing SDS-PAGE protein profiles in tracing a hospital outbreak of Serratia marcescens. J Infect (1988) 0.86
The genetics and physiology of coliphage N4. Virology (1973) 0.86
Different patterns of replication in influenza virus-infected KB cells. Arch Virol (1980) 0.85
Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns. Drugs (1997) 0.85
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance. Int J Antimicrob Agents (2007) 0.85
Antistaphylococcal activity of cefdinir, a new oral third-generation cephalosporin, alone and in combination with other antibiotics, at supra- and sub-MIC levels. J Antimicrob Chemother (1995) 0.83
Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections. Int J Antimicrob Agents (2004) 0.83
Short chain fatty acids present in periodontal pockets may play a role in human periodontal diseases. J Periodontal Res (1987) 0.82
The oxazolidinones as a new family of antimicrobial agent. Clin Microbiol Infect (2001) 0.82
The peculiar behaviour of coliphage P1vir mutants on restricting hosts. Microbios (1978) 0.82
Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin. New Microbiol (1993) 0.82
Bacteria involved in the blockage of biliary stents and their susceptibility to antibacterial agents. Eur J Clin Microbiol Infect Dis (1996) 0.82
Circulation in Italy of beta-lactamase-producing strains within the major groups of bacterial pathogens. Eur J Epidemiol (1990) 0.82
Prevalence of antimicrobial resistance in Streptococcus pneumoniae circulating in Italy: results of the Italian Epidemiological Observatory Survey (1997-1999). Microb Drug Resist (2001) 0.82
Post-antibiotic effect of azithromycin on respiratory tract pathogens. Drugs Exp Clin Res (1990) 0.81
Antibacterial profile of flurithromycin, a new macrolide. J Antimicrob Chemother (1992) 0.81
In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics. Chemioterapia (1987) 0.81
[Emergence of drug-resistant gram-positive pathogenic bacteria]. J Chemother (2000) 0.81
The Sentinel Project: an update on the prevalence of antimicrobial resistance in community-acquired respiratory Streptococcus pneumoniae and Haemophilus spp. in Italy. Int J Antimicrob Agents (2005) 0.80
Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens. J Chemother (1992) 0.79
Selectivity of transcription and structure of coliphage N4 virion-associated RNA polymerase. Biochem Biophys Res Commun (1978) 0.79
Evaluation of the trophic effect of human placental polydeoxyribonucleotide on human knee skin fibroblasts in primary culture. Cell Mol Life Sci (1997) 0.79
In vitro interactions between teicoplanin and other antibiotics against enterococci and staphylococci. J Hosp Infect (1986) 0.79
Antibacterial activity of the sulbactam-ampicillin combination. J Chemother (1989) 0.78
Increased energy expenditure by granulocytes during phagocytosis of Staphylococcus aureus compared with other staphylococci. J Infect Dis (1984) 0.78
Rapid evaluation of serum and gingival crevicular fluid immunoglobulin G subclass antibody levels in patients with early-onset periodontitis using checkerboard immunoblotting. Oral Microbiol Immunol (1998) 0.78
Parallel Western blot analysis for HIV-1 and HIV-2 antibodies: absence of HIV-2 infection in Italian subjects at risk for AIDS. AIDS (1988) 0.78